Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: An exploratory study

Diabetes Obes Metab. 2023 Sep;25(9):2780-2783. doi: 10.1111/dom.15161. Epub 2023 Jun 13.

Authors

Juri Künzler¹, Thomas Züger², Christoph Stettler¹, Markus Wolfgang Laimer¹, Andreas Melmer¹

Affiliations

¹ Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism UDEM, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
² Department of Endocrinology and Metabolic Diseases, Kantonsspital Olten, Olten, Switzerland.

PMID: 37311723
DOI: 10.1111/dom.15161

No abstract available

Keywords: CSII; insulin pump therapy; subcutaneous injection; type 1 diabetes.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Insulin Infusion Systems
Insulin, Regular, Human / therapeutic use
Pancreas, Artificial*
Reproducibility of Results

Substances

Insulin
Hypoglycemic Agents
Insulin, Regular, Human
Blood Glucose